Complete financial analysis of Oncoclínicas do Brasil Serviços Médicos S.A. (ONCO3.SA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Oncoclínicas do Brasil Serviços Médicos S.A., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Guangdong Join-Share Financing Guarantee Investment Co., Ltd. (1543.HK) Income Statement Analysis – Financial Results
- Invesco Perpetual Select Trust plc – Global Equity Income Share Portfolio (IVPG.L) Income Statement Analysis – Financial Results
- Plaza Holdings Co.,Ltd. (7502.T) Income Statement Analysis – Financial Results
- Clarkson PLC (CKNHF) Income Statement Analysis – Financial Results
- Selective Insurance Group, Inc. (SIGIP) Income Statement Analysis – Financial Results
Oncoclínicas do Brasil Serviços Médicos S.A. (ONCO3.SA)
About Oncoclínicas do Brasil Serviços Médicos S.A.
Oncoclínicas do Brasil Serviços Médicos S.A. provides medical services focused on clinical oncology and radiotherapy in Latin America. It offers services in the areas of chemotherapy, radiotherapy, hormone therapy, molecular target drugs, immunotherapy, bone marrow transplant, catheter heparinization, non-oncological infusions, laser therapy, myelogram - bone marrow biopsy, continuous care, and precision medicine. The company was founded in 2010 and is based in São Paulo, Brazil.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.49B | 4.09B | 2.70B | 2.04B | 1.69B | 1.05B | 791.84M | 594.81M | 457.97M | 359.45M | 269.14M |
| Cost of Revenue | 3.56B | 2.64B | 1.83B | 1.40B | 1.23B | 741.43M | 480.26M | 359.06M | 263.49M | 214.30M | 130.31M |
| Gross Profit | 1.93B | 1.45B | 868.79M | 635.68M | 460.53M | 309.41M | 311.58M | 235.75M | 194.48M | 145.16M | 138.83M |
| Gross Profit Ratio | 35.14% | 35.52% | 32.15% | 31.23% | 27.26% | 29.44% | 39.35% | 39.63% | 42.47% | 40.38% | 51.58% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 249.00K | 547.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.17B | 980.82M | 688.05M | 603.61M | 340.73M | 221.30M | 226.82M | 179.61M | 135.44M | 113.99M | 60.34M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.17B | 980.82M | 688.05M | 603.61M | 340.73M | 221.30M | 226.82M | 179.61M | 135.44M | 113.99M | 60.34M |
| Other Expenses | -1.51M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.17B | 981.01M | 691.58M | 616.06M | 338.77M | 237.68M | 243.93M | 196.52M | 149.48M | 117.90M | 70.15M |
| Cost & Expenses | 4.73B | 3.62B | 2.52B | 2.02B | 1.57B | 979.11M | 724.19M | 555.58M | 412.97M | 332.20M | 200.45M |
| Interest Income | 22.50M | 6.76M | 3.08M | 741.00K | 1.27M | 1.03M | 6.88M | 20.91M | 28.42M | 17.65M | 8.02M |
| Interest Expense | 559.79M | 396.47M | 154.36M | 72.07M | 41.61M | 26.61M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 257.37M | 175.15M | 126.97M | 106.81M | 64.10M | 17.93M | 11.61M | 13.49M | 8.39M | 5.56M | 1.09M |
| EBITDA | 1.17B | 730.36M | 337.08M | 126.43M | 196.11M | 95.98M | 54.43M | 55.68M | 49.51M | 23.92M | 80.16M |
| EBITDA Ratio | 21.28% | 17.32% | 12.60% | 5.94% | 11.01% | 9.36% | 6.87% | 9.36% | 10.81% | 6.66% | 29.79% |
| Operating Income | 758.02M | 470.57M | 177.22M | 19.62M | 121.76M | 82.74M | 42.83M | 42.19M | 41.12M | 18.37M | 79.08M |
| Operating Income Ratio | 13.81% | 11.51% | 6.56% | 0.96% | 7.21% | 7.87% | 5.41% | 7.09% | 8.98% | 5.11% | 29.38% |
| Total Other Income/Expenses | -455.50M | -349.03M | -114.88M | -85.32M | -41.39M | -28.97M | -7.39M | -21.63M | -24.54M | -21.57M | -8.47M |
| Income Before Tax | 302.52M | 121.54M | 62.34M | -57.12M | 80.37M | 53.77M | 60.77M | 18.33M | 16.58M | 9.60M | 60.66M |
| Income Before Tax Ratio | 5.51% | 2.97% | 2.31% | -2.81% | 4.76% | 5.12% | 7.67% | 3.08% | 3.62% | 2.67% | 22.54% |
| Income Tax Expense | -10.04M | 7.77M | 84.75M | 68.09M | 61.27M | 37.51M | 25.39M | 19.25M | 19.16M | 16.64M | 21.15M |
| Net Income | 223.62M | 46.26M | -46.90M | -159.62M | -20.42M | -17.08M | 3.15M | -25.36M | -24.77M | -22.17M | 20.50M |
| Net Income Ratio | 4.07% | 1.13% | -1.74% | -7.84% | -1.21% | -1.63% | 0.40% | -4.26% | -5.41% | -6.17% | 7.62% |
| EPS | 0.43 | 0.10 | -0.10 | -39.41 | -5.10 | -0.05 | 0.00 | -0.11 | -0.14 | -1.02 | 0.00 |
| EPS Diluted | 0.42 | 0.09 | -0.10 | -39.41 | -5.10 | -0.05 | 0.00 | -0.11 | -0.14 | -1.02 | 0.00 |
| Weighted Avg Shares Out | 523.65M | 479.83M | 474.78M | 4.05M | 4.00M | 359.09M | 31.45B | 225.04M | 171.47M | 21.70M | 0.00 |
| Weighted Avg Shares Out (Dil) | 535.52M | 531.70M | 474.78M | 4.05M | 4.00M | 359.09M | 31.45B | 225.04M | 171.47M | 21.70M | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports